BAXTER INTERNATIONAL INC (1BAX.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1BAX - US0718131099 - Common Stock
30.905 EUR
+0.18 (+0.57%)
Overall 1BAX gets a fundamental rating of 3 out of 10. We evaluated 1BAX against 68 industry peers in the Health Care Equipment & Supplies industry. 1BAX may be in some trouble as it scores bad on both profitability and health. 1BAX has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
1BAX had positive earnings in the past year.
In the past year 1BAX had a positive cash flow from operations.
In multiple years 1BAX reported negative net income over the last 5 years.
1BAX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.52%, 1BAX is in line with its industry, outperforming 40.35% of the companies in the same industry.
The Return On Equity of 1BAX (-9.32%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 3.45%, 1BAX is in line with its industry, outperforming 49.12% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1BAX is significantly below the industry average of 9.73%.
The last Return On Invested Capital (3.45%) for 1BAX is above the 3 year average (3.20%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.52% | ||
| ROE | -9.32% | ||
| ROIC | 3.45% |
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
1.3 Margins
1BAX has a Operating Margin of 7.67%. This is comparable to the rest of the industry: 1BAX outperforms 56.14% of its industry peers.
1BAX's Operating Margin has declined in the last couple of years.
The Gross Margin of 1BAX (38.01%) is worse than 71.93% of its industry peers.
In the last couple of years the Gross Margin of 1BAX has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.67% | ||
| PM (TTM) | N/A | ||
| GM | 38.01% |
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1BAX is destroying value.
1BAX has more shares outstanding than it did 1 year ago.
1BAX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 1BAX is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.10 indicates that 1BAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
1BAX's Altman-Z score of 2.10 is in line compared to the rest of the industry. 1BAX outperforms 57.89% of its industry peers.
The Debt to FCF ratio of 1BAX is 22.91, which is on the high side as it means it would take 1BAX, 22.91 years of fcf income to pay off all of its debts.
1BAX's Debt to FCF ratio of 22.91 is in line compared to the rest of the industry. 1BAX outperforms 50.88% of its industry peers.
A Debt/Equity ratio of 1.79 is on the high side and indicates that 1BAX has dependencies on debt financing.
1BAX's Debt to Equity ratio of 1.79 is on the low side compared to the rest of the industry. 1BAX is outperformed by 82.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 22.91 | ||
| Altman-Z | 2.1 |
ROIC/WACC0.53
WACC6.49%
2.3 Liquidity
1BAX has a Current Ratio of 1.36. This is a normal value and indicates that 1BAX is financially healthy and should not expect problems in meeting its short term obligations.
1BAX's Current ratio of 1.36 is in line compared to the rest of the industry. 1BAX outperforms 45.61% of its industry peers.
1BAX has a Quick Ratio of 1.05. This is a normal value and indicates that 1BAX is financially healthy and should not expect problems in meeting its short term obligations.
1BAX has a Quick ratio (1.05) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.37% over the past year.
The Earnings Per Share has been decreasing by -4.21% on average over the past years.
The Revenue for 1BAX has decreased by -13.21% in the past year. This is quite bad
The Revenue has been decreasing by -1.31% on average over the past years.
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%
3.2 Future
The Earnings Per Share is expected to grow by 6.87% on average over the next years.
1BAX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.61% yearly.
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.61 indicates a correct valuation of 1BAX.
Compared to the rest of the industry, the Price/Earnings ratio of 1BAX indicates a rather cheap valuation: 1BAX is cheaper than 89.47% of the companies listed in the same industry.
1BAX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.19.
1BAX is valuated correctly with a Price/Forward Earnings ratio of 13.58.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BAX indicates a somewhat cheap valuation: 1BAX is cheaper than 75.44% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of 1BAX to the average of the S&P500 Index (23.92), we can say 1BAX is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.61 | ||
| Fwd PE | 13.58 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BAX indicates a somewhat cheap valuation: 1BAX is cheaper than 78.95% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, 1BAX is valued a bit cheaper than the industry average as 73.68% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.59 | ||
| EV/EBITDA | 13.5 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.96%
EPS Next 3Y3.75%
5. Dividend
5.1 Amount
1BAX has a Yearly Dividend Yield of 2.17%.
1BAX's Dividend Yield is rather good when compared to the industry average which is at 1.13. 1BAX pays more dividend than 80.70% of the companies in the same industry.
1BAX's Dividend Yield is comparable with the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
5.2 History
The dividend of 1BAX is nicely growing with an annual growth rate of 6.89%!
Dividend Growth(5Y)6.89%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
The earnings of 1BAX are negative and hence is the payout ratio. 1BAX will probably not be able to sustain this dividend level.
The dividend of 1BAX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-90.91%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
BIT:1BAX (3/26/2025, 7:00:00 PM)
30.905
+0.18 (+0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.07%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap15.85B
Revenue(TTM)12.86B
Net Income(TTM)-649.00M
Analysts68.18
Price Target35.44 (14.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
Yearly Dividend1.05
Dividend Growth(5Y)6.89%
DP-90.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.32%
Min EPS beat(2)1.94%
Max EPS beat(2)10.69%
EPS beat(4)4
Avg EPS beat(4)5.06%
Min EPS beat(4)1.64%
Max EPS beat(4)10.69%
EPS beat(8)7
Avg EPS beat(8)3.73%
EPS beat(12)8
Avg EPS beat(12)2.99%
EPS beat(16)12
Avg EPS beat(16)4.13%
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)1.93%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)-0.57%
Revenue beat(12)4
Avg Revenue beat(12)-1.99%
Revenue beat(16)5
Avg Revenue beat(16)-2.54%
PT rev (1m)-3.81%
PT rev (3m)-3.81%
EPS NQ rev (1m)-31.48%
EPS NQ rev (3m)-31.48%
EPS NY rev (1m)-22.05%
EPS NY rev (3m)-22.05%
Revenue NQ rev (1m)-30.35%
Revenue NQ rev (3m)-30.35%
Revenue NY rev (1m)-28.82%
Revenue NY rev (3m)-28.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.61 | ||
| Fwd PE | 13.58 | ||
| P/S | 1.36 | ||
| P/FCF | 30.59 | ||
| P/OCF | 17.2 | ||
| P/B | 2.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.5 |
EPS(TTM)2.45
EY7.93%
EPS(NY)2.28
Fwd EY7.36%
FCF(TTM)1.01
FCFY3.27%
OCF(TTM)1.8
OCFY5.81%
SpS22.67
BVpS12.28
TBVpS-6.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.52% | ||
| ROE | -9.32% | ||
| ROCE | 5.12% | ||
| ROIC | 3.45% | ||
| ROICexc | 3.76% | ||
| ROICexgc | 8.07% | ||
| OM | 7.67% | ||
| PM (TTM) | N/A | ||
| GM | 38.01% | ||
| FCFM | 4.46% |
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
ROICexc(3y)3.57%
ROICexc(5y)5.33%
ROICexgc(3y)9.57%
ROICexgc(5y)12.38%
ROCE(3y)4.43%
ROCE(5y)6.16%
ROICexgc growth 3Y-30.34%
ROICexgc growth 5Y-21.96%
ROICexc growth 3Y-22.52%
ROICexc growth 5Y-26.32%
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
F-Score3
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 22.91 | ||
| Debt/EBITDA | 6.3 | ||
| Cap/Depr | 44.73% | ||
| Cap/Sales | 3.47% | ||
| Interest Coverage | 4.42 | ||
| Cash Conversion | 51.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.1 |
F-Score3
WACC6.49%
ROIC/WACC0.53
Cap/Depr(3y)49.31%
Cap/Depr(5y)63.51%
Cap/Sales(3y)5.12%
Cap/Sales(5y)5.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%
EBIT growth 1Y-21.12%
EBIT growth 3Y-30.01%
EBIT growth 5Y-18.5%
EBIT Next Year69.69%
EBIT Next 3Y22.35%
EBIT Next 5Y25.92%
FCF growth 1Y-44.58%
FCF growth 3Y-27.1%
FCF growth 5Y-16.46%
OCF growth 1Y-40.96%
OCF growth 3Y-22.88%
OCF growth 5Y-13.5%
BAXTER INTERNATIONAL INC / 1BAX.MI FAQ
What is the ChartMill fundamental rating of BAXTER INTERNATIONAL INC (1BAX.MI) stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1BAX.MI.
Can you provide the valuation status for BAXTER INTERNATIONAL INC?
ChartMill assigns a valuation rating of 5 / 10 to BAXTER INTERNATIONAL INC (1BAX.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for BAXTER INTERNATIONAL INC?
BAXTER INTERNATIONAL INC (1BAX.MI) has a profitability rating of 3 / 10.
What is the valuation of BAXTER INTERNATIONAL INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BAXTER INTERNATIONAL INC (1BAX.MI) is 12.61 and the Price/Book (PB) ratio is 2.52.
Can you provide the dividend sustainability for 1BAX stock?
The dividend rating of BAXTER INTERNATIONAL INC (1BAX.MI) is 4 / 10 and the dividend payout ratio is -90.91%.